The Potential Placebo Effect of Advanced Footwear Technology on Running Economy, Biomechanics and Comfort in Female Recreational Runners
- Conditions
- Cardiovascular fitnessLower extremity biomechanicsMusculoskeletal painCardiovascular - Normal development and function of the cardiovascular systemMusculoskeletal - Normal musculoskeletal and cartilage development and function
- Registration Number
- ACTRN12623000731695
- Lead Sponsor
- niversity of Waikato
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Female
- Target Recruitment
- 26
Twenty-six female recreational runners who are comfortable running on a treadmill will be recruited for this study. More specifically, participants will be included if they have been running for more than six months regularly, run 1 to 5 times a week, and run a 5 km distance above 20 minutes. Participants will also be required to be able to run comfortably for 45 minutes in total. Runners will also have to fit the available shoe sizes (7.5 to 9.5 US)
Runners will be excluded if they are currently injured or have been injured in the last month according to the following consensus definition: Running related (training or competition) musculoskeletal pain in the lower limbs that causes a restriction on or stoppage of running (distance, speed, duration, or training) for at least 7 days or 3 consecutive scheduled training sessions, or that requires the runner to consult a physician or other health professional.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Oxygen consumption (mL/kg/min) using a Metabolic cart (Parvo Medic TrueOne), VO2 values will be collected every 15 seconds throughout each running economy trial.[The two highest concurrent VO2 values in the final minute of each running economy trial will be averaged and used to calculate oxygen consumption.]
- Secondary Outcome Measures
Name Time Method